Contact
Please use this form to send email to PR contact of this press release:
Favorable Federal Reclassification of Specialty Botanical Products Unlocks Major Opportunity for Acquisition: OTC: CATV
TO:
Michael Feldenkrais, CEO
Category V Biotech, Inc.
+1 786-652-3200